​

Connect Biopharma (CNTB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Connect Biopharma Revenue Highlights

00

Main Segment (Y)

License

Connect Biopharma Revenue by Period

Connect Biopharma Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$26.03M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Connect Biopharma generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Connect Biopharma Revenue by Quarter

DateRevenueChange
2025-12-31--100.00%
2025-06-30$48.00K-93.12%
2024-12-31$698.00K-97.11%
2024-06-30$24.12M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2021-12-31-100.00%
2021-06-30-100.00%
2020-12-31-100.00%
2020-06-30-100.00%
2019-12-31-100.00%
2019-06-30--

Connect Biopharma generated - in revenue during Q4 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Connect Biopharma Revenue Breakdown

Connect Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
License$110.00M$24.40M

Connect Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25
License-$110.00M

Connect Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
STROSutro Biopharma$102.48M$14.52M
MGXMetagenomi$25.21M$1.25M
OVIDOvid Therapeutics$7.25M-
STTKShattuck Labs$1.00M-
IFRXInflaRx$61.80K$36.25K
CNTXContext Therapeutics--
CNTBConnect Biopharma--
ARTVArtiva Biotherapeutics--
QNCXQuince Therapeutics--
KLRSKalaris Therapeutics--
IMAImageneBio--

CNTB Revenue FAQ

What is Connect Biopharma’s yearly revenue?

Connect Biopharma's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $26.03M, representing an increase of 100.00% compared to 2023. CNTB's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Connect Biopharma’s quarterly revenue?

Connect Biopharma's quarterly revenue for Q4 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q4 2023). The company's quarterly revenue for Q2 2025 was $48K, a -93.12% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q3 2023). CNTB's quarterly revenue for Q4 2024 was $698K, a -97.11% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q2 2023).

What is Connect Biopharma’s revenue growth rate?

Connect Biopharma's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Connect Biopharma’s revenue streams?

Connect Biopharma's revenue streams in c 25 are License

What is Connect Biopharma’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Connect Biopharma was License. This segment made a revenue of $110M, representing 100.00% of the company's total revenue.